Changes in circulating parasite antigen levels after treatment of bancroftian filariasis with diethylcarbamazine and ivermectin
- PMID: 1894943
- DOI: 10.1093/infdis/164.4.814
Changes in circulating parasite antigen levels after treatment of bancroftian filariasis with diethylcarbamazine and ivermectin
Abstract
This study assessed changes in circulating parasite antigen levels after diethylcarbamazine (DEC) and ivermectin treatment of bancroftian filariasis to determine effects of these drugs on adult Wuchereria bancrofti in vivo. Thirty adult Haitians with microfilaremia were treated with 1 mg of ivermectin to reduce counts of microfilariae. Later, subjects were treated with either one or two 200 micrograms/kg doses of ivermectin or with 12 daily 6 mg/kg doses of DEC. Macrofilaricidal activity of these drugs was indirectly monitored by measuring circulating W. bancrofti antigen by EIA. Antigen levels fell by 75% after DEC and by 34% after ivermectin. These results suggest that low-dose ivermectin treatment followed by a standard course of DEC is a more effective macrofilaricidal regimen for W. bancrofti than either of the multidose ivermectin regimens used in this study.
Similar articles
-
Kinetics of circulating human IgG4 after diethylcarbamazine and ivermectin treatment of bancroftian filariasis.J Infect Dis. 1992 Jun;165(6):1158-60. doi: 10.1093/infdis/165.6.1158. J Infect Dis. 1992. PMID: 1583340 Clinical Trial.
-
Comparison of single-dose diethylcarbamazine and ivermectin for treatment of bancroftian filariasis in Papua New Guinea.Am J Trop Med Hyg. 1993 Dec;49(6):804-11. doi: 10.4269/ajtmh.1993.49.804. Am J Trop Med Hyg. 1993. PMID: 8279647 Clinical Trial.
-
Prolonged clearance of microfilaraemia in patients with bancroftian filariasis after multiple high doses of ivermectin or diethylcarbamazine.Trans R Soc Trop Med Hyg. 1996 Nov-Dec;90(6):684-8. doi: 10.1016/s0035-9203(96)90437-x. Trans R Soc Trop Med Hyg. 1996. PMID: 9015519 Clinical Trial.
-
Model-based analysis of trial data: microfilaria and worm-productivity loss after diethylcarbamazine-albendazole or ivermectin-albendazole combination therapy against Wuchereria bancrofti.Trop Med Int Health. 2006 May;11(5):718-28. doi: 10.1111/j.1365-3156.2006.01606.x. Trop Med Int Health. 2006. PMID: 16640625 Review.
-
The role of albendazole in programmes to eliminate lymphatic filariasis.Parasitol Today. 1999 Sep;15(9):382-6. doi: 10.1016/s0169-4758(99)01486-6. Parasitol Today. 1999. PMID: 10461168 Review.
Cited by
-
Impact of microfilaremia on maintenance of a hyporesponsive cellular immune response in Brugia-infected gerbils (Meriones unguiculatus).Infect Immun. 1995 Mar;63(3):940-5. doi: 10.1128/iai.63.3.940-945.1995. Infect Immun. 1995. PMID: 7868266 Free PMC article.
-
Adverse events following single dose treatment of lymphatic filariasis: Observations from a review of the literature.PLoS Negl Trop Dis. 2018 May 16;12(5):e0006454. doi: 10.1371/journal.pntd.0006454. eCollection 2018 May. PLoS Negl Trop Dis. 2018. PMID: 29768412 Free PMC article. Review.
-
Changes in Cytokine, Filarial Antigen, and DNA Levels Associated With Adverse Events Following Treatment of Lymphatic Filariasis.J Infect Dis. 2018 Jan 4;217(2):280-287. doi: 10.1093/infdis/jix578. J Infect Dis. 2018. PMID: 29149303 Free PMC article.
-
Current perspectives in the epidemiology and control of lymphatic filariasis.Clin Microbiol Rev. 2025 Jun 12;38(2):e0012623. doi: 10.1128/cmr.00126-23. Epub 2025 Apr 2. Clin Microbiol Rev. 2025. PMID: 40172233 Review.
-
Review of Dancing Parasites in Lymphatic Filariasis.Ultrasound Int Open. 2019 Mar;5(2):E65-E74. doi: 10.1055/a-0918-3678. Epub 2019 Jul 15. Ultrasound Int Open. 2019. PMID: 31312785 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials